The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1104
ISSUE 1104
May 14, 2001
Issue 1104
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Formoterol (Foradil Aerolizer) For Asthma
May 14, 2001 (Issue: 1104)
Formoterol fumarate inhalation powder Foradil Aerolizer, a long-acting beta2-adrenergic receptor agonist, has been approved by the FDA for maintenance treatment of asthma and prevention of exercise-induced bronchospasm. The drug has been available in...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.